Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells

✍ Scribed by Xia, Wenle; Gerard, Catherine M; Liu, Leihua; Baudson, Nathalie M; Ory, Thierry L; Spector, Neil L

• Book ID: 110069819
• Publisher: Nature Publishing Group
• Year: 2005
• Tongue: English
• Weight: 235 KB
• Volume: 24
• Category: Article
• ISSN: 0950-9232
• DOI: 10.1038/sj.onc.1208774